Cite
Hiramine S, Furusyo N, Ogawa E, et al. Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C. World J Hepatol. 2015;7(26):2688-95doi: 10.4254/wjh.v7.i26.2688.
Hiramine, S., Furusyo, N., Ogawa, E., Nakamuta, M., Kajiwara, E., Nomura, H., Dohmen, K., Takahashi, K., Satoh, T., Azuma, K., Kawano, A., Koyanagi, T., Kotoh, K., Shimoda, S., & Hayashi, J. (2015). Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C. World journal of hepatology, 7(26), 2688-95. https://doi.org/10.4254/wjh.v7.i26.2688
Hiramine, Satoshi, et al. "Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C." World journal of hepatology vol. 7,26 (2015): 2688-95. doi: https://doi.org/10.4254/wjh.v7.i26.2688
Hiramine S, Furusyo N, Ogawa E, Nakamuta M, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Satoh T, Azuma K, Kawano A, Koyanagi T, Kotoh K, Shimoda S, Hayashi J. Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C. World J Hepatol. 2015 Nov 18;7(26):2688-95. doi: 10.4254/wjh.v7.i26.2688. PMID: 26609346; PMCID: PMC4651913.
Copy
Download .nbib